Latest News

EV/pembrolizumab under review in China for advanced urothelial carcinoma
EV/pembrolizumab under review in China for advanced urothelial carcinoma

March 28th 2024

The sBLA is supported by findings from the phase 3 EV-302 trial, which showed that EV/pembrolizumab extended overall survival and progression-free survival vs platinum-based chemotherapy in patients with advanced urothelial carcinoma.

Active surveillance does not increase malpractice risk across cancers
Active surveillance does not increase malpractice risk across cancers

March 28th 2024

Person using calculator and taking notes | Image Credit: © Nuttapong punna - stock.adobe.com
Potential code for prior authorizations on AMA CPT Editorial Panel meeting agenda

March 28th 2024

Urine-based assay demonstrates predictive efficacy in MIBC
Urine-based assay demonstrates predictive efficacy in MIBC

March 27th 2024

Circulating biomarkers are prognostic for radium-223 benefit in mCRPC
Circulating biomarkers are prognostic for radium-223 benefit in mCRPC

March 27th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.